0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lymphoma"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$4,750USDGBP
Immuno-oncology Market - Product Thumbnail Image

Immuno-oncology Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
From
EUR$9,500USDGBP
From
EUR$4,950USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$3,250USDGBP
EUR$4,850USDGBP
From
EUR$4,150USDGBP
Interventional Oncology Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Interventional Oncology Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
From
EUR$4,949USDGBP
From
EUR$34,500USDGBP
Oncology Markets for Tyrokinse Kinase Inhibitors - Product Thumbnail Image

Oncology Markets for Tyrokinse Kinase Inhibitors

  • Report
  • October 2021
  • 137 Pages
  • Global
From
EUR$4,850USDGBP
Market Spotlight: Cutaneous T-Cell Lymphoma (CTCL) - Product Thumbnail Image

Market Spotlight: Cutaneous T-Cell Lymphoma (CTCL)

  • Report
  • May 2021
  • 45 Pages
  • Global
EUR$1,318USDGBP
Loading Indicator

Lymphoma is a type of hematological malignancy that originates in the lymphatic system. It is characterized by the uncontrolled growth of lymphocytes, a type of white blood cell. Lymphomas can be either Hodgkin's or non-Hodgkin's, and can be either indolent or aggressive. Treatment options for lymphoma include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies. The lymphoma market is a subset of the larger hematology market, which includes treatments for a variety of blood-related diseases. The lymphoma market is driven by the increasing prevalence of the disease, as well as the development of new treatments. Companies in the lymphoma market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Gilead Sciences, Novartis, and Pfizer. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more